Pevahouse J B, Markandu N D, Cappuccio F P, Buckley M G, Sagnella G A, MacGregor G A
Department of Medicine, St George's Hospital Medical School, London.
BMJ. 1990 Sep 22;301(6752):580-4. doi: 10.1136/bmj.301.6752.580.
To assess the changes in sodium excretion and sodium balance after withdrawal of long term nifedipine.
Single blind, placebo controlled study in patients receiving fixed sodium and potassium intakes.
Blood pressure unit of a teaching hospital in south London.
Eight patients with mild to moderate uncomplicated essential hypertension who had been taking nifedipine 20 mg twice daily for at least six weeks.
Withdrawal of nifedipine and replacement with matching placebo for one week.
Urinary sodium excretion and cumulative sodium balance, body weight, plasma atrial natriuretic peptide concentrations, plasma renin activity and aldosterone concentrations, and blood pressure.
During nifedipine withdrawal there was a significant reduction in urinary sodium excretion (day 1: -62.7 mmol/24 h; 95% confidence interval -90.3 to -35.0) and each patient retained a mean of 146 (SEM 26) mmol sodium over the week of replacement with placebo. Body weight and plasma atrial natriuretic peptide concentrations increased during the placebo period and seemed to be associated with the amount of sodium retained. Systolic blood pressure rose from 157 (9) to 165 (9) mmHg (95% confidence interval of difference -7.1 to 22.1) when nifedipine was replaced with matching placebo, and the rise seemed to be related to the amount of sodium that was retained.
Nifedipine causes a long term reduction in sodium balance in patients with essential hypertension. This long term effect may contribute to the mechanism whereby nifedipine lowers blood pressure.
评估长期停用硝苯地平后钠排泄及钠平衡的变化。
在固定钠和钾摄入量的患者中进行的单盲、安慰剂对照研究。
伦敦南部一家教学医院的血压科室。
8例轻度至中度无并发症的原发性高血压患者,他们每日服用20 mg硝苯地平两次,至少服用了六周。
停用硝苯地平,换用匹配的安慰剂,为期一周。
尿钠排泄、累积钠平衡、体重、血浆心钠素浓度、血浆肾素活性和醛固酮浓度以及血压。
在停用硝苯地平期间,尿钠排泄显著减少(第1天:-62.7 mmol/24小时;95%置信区间-90.3至-35.0),在换用安慰剂的一周内,每位患者平均潴留146(标准误26)mmol钠。在安慰剂期体重和血浆心钠素浓度升高,且似乎与潴留的钠量有关。当用匹配的安慰剂替代硝苯地平时,收缩压从157(9)mmHg升至165(9)mmHg(差异的95%置信区间为-7.1至22.1),血压升高似乎与潴留的钠量有关。
硝苯地平可使原发性高血压患者的钠平衡长期降低。这种长期效应可能有助于硝苯地平降低血压的机制。